About Us

Impact Biomedical drives mission-oriented discovery and development to pursue new products and treatment options in specialty biopharmaceuticals and consumer healthcare.

Our biopharmaceutical technologies have potential to advance treatment in oncology, neurology, and immunology. Consumer efforts include naturally based sugar alternatives, fragrances and insect repellents, as well antibacterial, antiviral, and antimicrobial technologies. A true spirit and desire of continuous improvement in healthcare result in continuous discovery of new technologies.

Core Technologies

3F™ (Functional Fragrance Formulation) is a unique formulation of specialized ingredients (e.g. terpenes) from botanical sources with demonstrated effect as an insect repellent and an antimicrobial..

Equivir/Nemovir technology is a novel blend of FDA Generally Recognized as Safe (GRAS) eligible polyphenols that have proven antiviral effects with additional potential applications such as medication or supplements. .

LineBacker is a platform of small molecule X-bonded polyphenols. X-bonding is a molecular tuning technique that modifies a natural compound to induce potency, efficacy, bioavailability, without compromising safety standards..

Laetose™ technology is derived from a unique combination of sugar and inositol, which demonstrates the ability to inhibit the inflammatory and metabolic response of sugar alone, making it an ideal alternative..

Advisors

Board of Directors

Heng Fai Ambrose Chan

Chief Executive Officer and Chairman of the Board

Frank D. Heuszel

President and Director

Elise Brownell

Founding Partner

John “JT” Thatch

Chief Executive Officer